ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Water → Benzenesulfonate 3-[({5-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-4-methyl-2-oxo-3-[3-(trifluoromethyl)phenyl]-2,3-dihydro-1H-imidazol-1-yl}carbonyl)amino]-N,N,N-trimethylpropan-1-aminium

HRID 1480029
印刷

反応式

HRID 1480029 の反応式
[C:1]1([S:7]([O:10]C)(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.[C:12]([C:14]1[CH:19]=[CH:18][C:17]([N:20]2[C:24]([C:25]3[N:29]([C:30]([NH:32][CH2:33][CH2:34][CH2:35][N:36]([CH3:38])[CH3:37])=[O:31])[C:28](=[O:39])[N:27]([C:40]4[CH:45]=[CH:44][CH:43]=[C:42]([C:46]([F:49])([F:48])[F:47])[CH:41]=4)[C:26]=3[CH3:50])=[CH:23][CH:22]=[N:21]2)=[CH:16][CH:15]=1)#[N:13].O.CCOC(C)=O>C1COCC1>[C:12]([C:14]1[CH:19]=[CH:18][C:17]([N:20]2[C:24]([C:25]3[N:29]([C:30]([NH:32][CH2:33][CH2:34][CH2:35][N+:36]([CH3:1])([CH3:37])[CH3:38])=[O:31])[C:28](=[O:39])[N:27]([C:40]4[CH:45]=[CH:44][CH:43]=[C:42]([C:46]([F:49])([F:47])[F:48])[CH:41]=4)[C:26]=3[CH3:50])=[CH:23][CH:22]=[N:21]2)=[CH:16][CH:15]=1)#[N:13].[C:1]1([S:7]([O-:10])(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 962WaterHCID 6630Methyl benzenesulfonateHCID 8857Ethyl AcetateHCID 1213937355-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-N-[3-(dimethylamino)propyl]-4-methyl-2-oxo-3-[3-(trifluoromethyl)phenyl]-2,3-dihydro-1H-imidazole-1-carboxamide

生成物 1

HCID 121393709
Benzenesulfonate 3-[({5-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-4-methyl-2-oxo-3-[3-(trifluoromethyl)phenyl]-2,3-dihydro-1H-imidazol-1-yl}carbonyl)amino]-N,N,N-trimethylpropan-1-aminium
収率 140.9%

試薬・触媒・溶媒 1

HCID 8028Tetrahydrofuran溶媒

実験手順

Methyl benzenesulfonate (0.019 mL, 0.14 mmol) was added to a solution of 5-[1-(4-cyanophenyl)-1H-pyrazol-5-yl]-N-[3-(dimethylamino)propyl]-4-methyl-2-oxo-3-[3-(trifluoromethyl)phenyl]-2,3-dihydro-1H-imidazole-1-carboxamide (Example 9) (77 mg, 0.14 mmol) in THF (3.0 mL). The mixture was stirred for 2 hr then allowed to stand at RT for 2 days. Water (15 mL) and EtOAc (15 ml) were added with stirring. The phases were separated. The aqueous phase was washed with EtOAc (15 mL) then diluted with MeCN. The solvents were removed by lyophilisation to afford the title compound (70 mg) a white solid.

後処理

  1. waitto stand at RT for 2 days
  2. stirringwith stirring
  3. customThe phases were separated
  4. washThe aqueous phase was washed with EtOAc (15 mL)
  5. additionthen diluted with MeCN
  6. customThe solvents were removed by lyophilisation

出典と根拠

ORDレコード
ord-f65d8d27850047059ca48995a8d1e035
出典データセット
uspto-grants-2016_08
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09409870B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート